Minjie Wang

Union Hospital
Wuhan, 430022, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Evaluation of an integrated micro-skills training and clinical pathway model in surgical internship education.

Evaluation of an integrated micro-skills training and clinical pathway model in surgical internship education.

Journal: PeerJ
Published: January 22, 2026

Integrative Analysis of Cytotoxic Lymphocytes-Mediated Tumour Killing Related Genes Reveals LDHA as a Novel Glioblastoma Therapeutic Target.

Integrative Analysis of Cytotoxic Lymphocytes-Mediated Tumour Killing Related Genes Reveals LDHA as a Novel Glioblastoma Therapeutic Target.

Journal: Journal of cellular and molecular medicine
Published: December 10, 2025

NIBAN2/FLII/RREB1 Axis Drives Glioma Stem Cell Malignancy via TLR3 Pathway Activation.

NIBAN2/FLII/RREB1 Axis Drives Glioma Stem Cell Malignancy via TLR3 Pathway Activation.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 05, 2025

MRPS16 Regulates NFATC2 Through the Wnt/β-Catenin Pathway to Promote Glioma Proliferation.

MRPS16 Regulates NFATC2 Through the Wnt/β-Catenin Pathway to Promote Glioma Proliferation.

Journal: Journal of cellular and molecular medicine
Published: September 01, 2025

Targeted suppression of glioma by ultralow-dose x-ray-induced photodynamic therapy and gold-based nanoclusters in preclinical models.

Targeted suppression of glioma by ultralow-dose x-ray-induced photodynamic therapy and gold-based nanoclusters in preclinical models.

Journal: Science translational medicine
Published: June 11, 2025

Characterization of Prognostic Apoptosis-Related Gene Signature to Evaluate Glioma Immune Microenvironment and Experimental Verification.

Characterization of Prognostic Apoptosis-Related Gene Signature to Evaluate Glioma Immune Microenvironment and Experimental Verification.

Journal: Genetic testing and molecular biomarkers
Published: January 31, 2024

Emerging trends and thematic evolution of immunotherapy for glioma based on the top 100 cited articles.

Emerging trends and thematic evolution of immunotherapy for glioma based on the top 100 cited articles.

Journal: Frontiers in oncology
Published: October 07, 2023

TXNDC12 knockdown promotes ferroptosis by modulating SLC7A11 expression in glioma.

TXNDC12 knockdown promotes ferroptosis by modulating SLC7A11 expression in glioma.

Journal: Clinical and translational science
Published: April 19, 2023

Tumor-Associated Macrophage-Derived Exosomal LINC01232 Induces the Immune Escape in Glioma by Decreasing Surface MHC-I Expression.

Tumor-Associated Macrophage-Derived Exosomal LINC01232 Induces the Immune Escape in Glioma by Decreasing Surface MHC-I Expression.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 30, 2022

Immune-related matrisomes are potential biomarkers to predict the prognosis and immune microenvironment of glioma patients.

Immune-related matrisomes are potential biomarkers to predict the prognosis and immune microenvironment of glioma patients.

Journal: FEBS open bio
Published: January 12, 2022

Natural killer cell awakening: unleash cancer-immunity cycle against glioblastoma.

Natural killer cell awakening: unleash cancer-immunity cycle against glioblastoma.

Journal: Cell death & disease
Published: November 29, 2021

MiR-193b as an effective biomarker in human cancer prognosis for Asian patients: a meta-analysis.

MiR-193b as an effective biomarker in human cancer prognosis for Asian patients: a meta-analysis.

Journal: Translational cancer research
Published: November 16, 2021
Showing 1-12 of 18

Last Updated: 09/26/2026